EXPERT REV PROTEOMIC 润色咨询

Expert Review of Proteomics

出版年份：2004 年文章数：723 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：6.5% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1090483, encodeId=82cd1090483f9, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090484, encodeId=af241090484da, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550362, encodeId=f6d8550362cb, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：主编特别邀请，主题是主编给的（可以适当更改）审稿速度2个月左右，2个审稿人。递交初稿的时候第一审稿人很正面，没有什么大问题；第二审稿人提的问题很多很尖锐。主编根据意见给出了“拒绝，但更改后可重新提交”。还注明说重新提交之后必须再审。 <br> <br> 我们根据问题修改和回信（回信都用了4千多字，就因为第二审稿人意见太多了）。结果主编说很满意，然后不到一个礼拜就接受了（好像也没有再审）。 <br> <br> 整体上主编很专业，审稿速度不错。因为是主编特邀，所以主题已经被定，但也因为如此所以应该不容易被拒（只要更改到他们满意为止）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=579e2094000, createdName=1467679538_58389919, createdTime=Tue Dec 26 16:34:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538014, encodeId=66fb53801496, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：蛋白组领域很不错的杂志，一般是约稿，也可以问编辑内容是不是适合这个杂志。大概两个月的审稿时间，虽然没买OA还是能被广泛引用。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52bd1732430, createdName=寧靜致遠9a702681, createdTime=Thu Jun 15 20:39:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483962, encodeId=66a34839620c, content=属于主编特邀综述，是一种荣誉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=553, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Proteomics, createdTime=Sun Aug 14 15:10:00 CST 2011, time=2011-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481413, encodeId=55e7481413a4, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=515, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-12-28 MS68862005

    评审和期刊编辑一般会询问什么问题？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1090483, encodeId=82cd1090483f9, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090484, encodeId=af241090484da, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550362, encodeId=f6d8550362cb, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：主编特别邀请，主题是主编给的（可以适当更改）审稿速度2个月左右，2个审稿人。递交初稿的时候第一审稿人很正面，没有什么大问题；第二审稿人提的问题很多很尖锐。主编根据意见给出了“拒绝，但更改后可重新提交”。还注明说重新提交之后必须再审。 <br> <br> 我们根据问题修改和回信（回信都用了4千多字，就因为第二审稿人意见太多了）。结果主编说很满意，然后不到一个礼拜就接受了（好像也没有再审）。 <br> <br> 整体上主编很专业，审稿速度不错。因为是主编特邀，所以主题已经被定，但也因为如此所以应该不容易被拒（只要更改到他们满意为止）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=579e2094000, createdName=1467679538_58389919, createdTime=Tue Dec 26 16:34:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538014, encodeId=66fb53801496, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：蛋白组领域很不错的杂志，一般是约稿，也可以问编辑内容是不是适合这个杂志。大概两个月的审稿时间，虽然没买OA还是能被广泛引用。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52bd1732430, createdName=寧靜致遠9a702681, createdTime=Thu Jun 15 20:39:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483962, encodeId=66a34839620c, content=属于主编特邀综述，是一种荣誉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=553, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Proteomics, createdTime=Sun Aug 14 15:10:00 CST 2011, time=2011-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481413, encodeId=55e7481413a4, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=515, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-12-27 MS54455111222

    评审和期刊编辑要求我补实验，就一定要补么，不补行不行？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1090483, encodeId=82cd1090483f9, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090484, encodeId=af241090484da, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550362, encodeId=f6d8550362cb, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：主编特别邀请，主题是主编给的（可以适当更改）审稿速度2个月左右，2个审稿人。递交初稿的时候第一审稿人很正面，没有什么大问题；第二审稿人提的问题很多很尖锐。主编根据意见给出了“拒绝，但更改后可重新提交”。还注明说重新提交之后必须再审。 <br> <br> 我们根据问题修改和回信（回信都用了4千多字，就因为第二审稿人意见太多了）。结果主编说很满意，然后不到一个礼拜就接受了（好像也没有再审）。 <br> <br> 整体上主编很专业，审稿速度不错。因为是主编特邀，所以主题已经被定，但也因为如此所以应该不容易被拒（只要更改到他们满意为止）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=579e2094000, createdName=1467679538_58389919, createdTime=Tue Dec 26 16:34:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538014, encodeId=66fb53801496, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：蛋白组领域很不错的杂志，一般是约稿，也可以问编辑内容是不是适合这个杂志。大概两个月的审稿时间，虽然没买OA还是能被广泛引用。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52bd1732430, createdName=寧靜致遠9a702681, createdTime=Thu Jun 15 20:39:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483962, encodeId=66a34839620c, content=属于主编特邀综述，是一种荣誉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=553, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Proteomics, createdTime=Sun Aug 14 15:10:00 CST 2011, time=2011-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481413, encodeId=55e7481413a4, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=515, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2017-12-26 1467679538_58389919

    审稿速度:2.0 | 投稿命中率:75.0
    经验分享：主编特别邀请，主题是主编给的（可以适当更改）审稿速度2个月左右，2个审稿人。递交初稿的时候第一审稿人很正面，没有什么大问题；第二审稿人提的问题很多很尖锐。主编根据意见给出了“拒绝，但更改后可重新提交”。还注明说重新提交之后必须再审。

    我们根据问题修改和回信（回信都用了4千多字，就因为第二审稿人意见太多了）。结果主编说很满意，然后不到一个礼拜就接受了（好像也没有再审）。

    整体上主编很专业，审稿速度不错。因为是主编特邀，所以主题已经被定，但也因为如此所以应该不容易被拒（只要更改到他们满意为止）。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1090483, encodeId=82cd1090483f9, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090484, encodeId=af241090484da, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550362, encodeId=f6d8550362cb, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：主编特别邀请，主题是主编给的（可以适当更改）审稿速度2个月左右，2个审稿人。递交初稿的时候第一审稿人很正面，没有什么大问题；第二审稿人提的问题很多很尖锐。主编根据意见给出了“拒绝，但更改后可重新提交”。还注明说重新提交之后必须再审。 <br> <br> 我们根据问题修改和回信（回信都用了4千多字，就因为第二审稿人意见太多了）。结果主编说很满意，然后不到一个礼拜就接受了（好像也没有再审）。 <br> <br> 整体上主编很专业，审稿速度不错。因为是主编特邀，所以主题已经被定，但也因为如此所以应该不容易被拒（只要更改到他们满意为止）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=579e2094000, createdName=1467679538_58389919, createdTime=Tue Dec 26 16:34:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538014, encodeId=66fb53801496, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：蛋白组领域很不错的杂志，一般是约稿，也可以问编辑内容是不是适合这个杂志。大概两个月的审稿时间，虽然没买OA还是能被广泛引用。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52bd1732430, createdName=寧靜致遠9a702681, createdTime=Thu Jun 15 20:39:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483962, encodeId=66a34839620c, content=属于主编特邀综述，是一种荣誉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=553, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Proteomics, createdTime=Sun Aug 14 15:10:00 CST 2011, time=2011-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481413, encodeId=55e7481413a4, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=515, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2017-06-15 寧靜致遠9a702681

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：蛋白组领域很不错的杂志，一般是约稿，也可以问编辑内容是不是适合这个杂志。大概两个月的审稿时间，虽然没买OA还是能被广泛引用。谢谢！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1090483, encodeId=82cd1090483f9, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090484, encodeId=af241090484da, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550362, encodeId=f6d8550362cb, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：主编特别邀请，主题是主编给的（可以适当更改）审稿速度2个月左右，2个审稿人。递交初稿的时候第一审稿人很正面，没有什么大问题；第二审稿人提的问题很多很尖锐。主编根据意见给出了“拒绝，但更改后可重新提交”。还注明说重新提交之后必须再审。 <br> <br> 我们根据问题修改和回信（回信都用了4千多字，就因为第二审稿人意见太多了）。结果主编说很满意，然后不到一个礼拜就接受了（好像也没有再审）。 <br> <br> 整体上主编很专业，审稿速度不错。因为是主编特邀，所以主题已经被定，但也因为如此所以应该不容易被拒（只要更改到他们满意为止）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=579e2094000, createdName=1467679538_58389919, createdTime=Tue Dec 26 16:34:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538014, encodeId=66fb53801496, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：蛋白组领域很不错的杂志，一般是约稿，也可以问编辑内容是不是适合这个杂志。大概两个月的审稿时间，虽然没买OA还是能被广泛引用。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52bd1732430, createdName=寧靜致遠9a702681, createdTime=Thu Jun 15 20:39:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483962, encodeId=66a34839620c, content=属于主编特邀综述，是一种荣誉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=553, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Proteomics, createdTime=Sun Aug 14 15:10:00 CST 2011, time=2011-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481413, encodeId=55e7481413a4, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=515, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-08-14 Proteomics

    属于主编特邀综述，是一种荣誉

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1090483, encodeId=82cd1090483f9, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090484, encodeId=af241090484da, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550362, encodeId=f6d8550362cb, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：主编特别邀请，主题是主编给的（可以适当更改）审稿速度2个月左右，2个审稿人。递交初稿的时候第一审稿人很正面，没有什么大问题；第二审稿人提的问题很多很尖锐。主编根据意见给出了“拒绝，但更改后可重新提交”。还注明说重新提交之后必须再审。 <br> <br> 我们根据问题修改和回信（回信都用了4千多字，就因为第二审稿人意见太多了）。结果主编说很满意，然后不到一个礼拜就接受了（好像也没有再审）。 <br> <br> 整体上主编很专业，审稿速度不错。因为是主编特邀，所以主题已经被定，但也因为如此所以应该不容易被拒（只要更改到他们满意为止）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=579e2094000, createdName=1467679538_58389919, createdTime=Tue Dec 26 16:34:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538014, encodeId=66fb53801496, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：蛋白组领域很不错的杂志，一般是约稿，也可以问编辑内容是不是适合这个杂志。大概两个月的审稿时间，虽然没买OA还是能被广泛引用。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52bd1732430, createdName=寧靜致遠9a702681, createdTime=Thu Jun 15 20:39:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483962, encodeId=66a34839620c, content=属于主编特邀综述，是一种荣誉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=553, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Proteomics, createdTime=Sun Aug 14 15:10:00 CST 2011, time=2011-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481413, encodeId=55e7481413a4, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=515, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-06-29 medwu

    看涨哦，明年会不会再涨？

    0

共8条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分